NeuroStar® Marks Two Years of Transformative Impact with NeuroStar University
August 20, 2024 08:29 ET
|
Neuronetics
MALVERN, Pa., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge
August 12, 2024 07:15 ET
|
Neuronetics
MALVERN, Pa. and TORONTO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (“Neuronetics”) and Greenbrook TMS Inc. (OTCMKTS: GBNHF) (“Greenbrook”) today announced that they have...
Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results
August 12, 2024 07:10 ET
|
Neuronetics
MALVERN, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of...
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 05, 2024 16:36 ET
|
Neuronetics
MALVERN, Pa., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month
August 01, 2024 08:29 ET
|
Neuronetics
MALVERN, Pa., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics to Present at the Canaccord Genuity 44th Annual Growth Conference
July 31, 2024 08:30 ET
|
Neuronetics
MALVERN, Pa., July 31, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors
July 30, 2024 08:30 ET
|
Neuronetics
MALVERN, Pa., July 30, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call
July 29, 2024 08:30 ET
|
Neuronetics
MALVERN, Pa., July 29, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Aetna Policy Update Expands TMS Availability for Adolescents With Depression
July 22, 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults
July 11, 2024 08:36 ET
|
Neuronetics
MALVERN, Pa., July 11, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...